BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10584926)

  • 1. Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II.
    Pan D; Shankar R; Stroncek DF; Whitley CB
    Hum Gene Ther; 1999 Nov; 10(17):2799-810. PubMed ID: 10584926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome.
    Stroncek DF; Hubel A; Shankar RA; Burger SR; Pan D; McCullough J; Whitley CB
    Transfusion; 1999 Apr; 39(4):343-50. PubMed ID: 10220258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).
    Braun SE; Pan D; Aronovich EL; Jonsson JJ; McIvor RS; Whitley CB
    Hum Gene Ther; 1996 Feb; 7(3):283-90. PubMed ID: 8835216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
    Pan D; Stroncek DF; Whitley CB
    J Gene Med; 2004 Dec; 6(12):1293-303. PubMed ID: 15538732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.
    Braun SE; Aronovich EL; Anderson RA; Crotty PL; McIvor RS; Whitley CB
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11830-4. PubMed ID: 8265633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral transduction of peripheral blood leukocytes in a hollow-fiber bioreactor.
    Shankar R; Whitley CB; Pan D; Burger S; McCullough J; Stroncek D
    Transfusion; 1997 Jul; 37(7):685-90. PubMed ID: 9225930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).
    Whitley CB; McIvor RS; Aronovich EL; Berry SA; Blazar BR; Burger SR; Kersey JH; King RA; Faras AJ; Latchaw RE; McCullough J; Pan D; Ramsay NK; Stroncek DF
    Hum Gene Ther; 1996 Mar; 7(4):537-49. PubMed ID: 8800749
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
    J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer.
    Di Francesco C; Cracco C; Tomanin R; Picci L; Ventura L; Zacchello E; Di Natale P; Anson DS; Hopwood JJ; Graham FL; Scarpa M
    Gene Ther; 1997 May; 4(5):442-8. PubMed ID: 9274721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II.
    Wakabayashi T; Shimada Y; Akiyama K; Higuchi T; Fukuda T; Kobayashi H; Eto Y; Ida H; Ohashi T
    Hum Gene Ther; 2015 Jun; 26(6):357-66. PubMed ID: 25761450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy.
    Jung SC; Park ES; Choi EN; Kim CH; Kim SJ; Jin DK
    Mol Cells; 2010 Jul; 30(1):13-8. PubMed ID: 20652491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Freezing characteristics of genetically modified lymphocytes for the treatment of MPS II.
    Hubel A; Darr TB; Norman JA
    Cell Transplant; 1999; 8(5):521-30. PubMed ID: 10580346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy.
    Stockschläder M; Haiss M; Exner S; Schmah O; Veelken H; Follo M; Rüger R; Finke J
    J Hematother Stem Cell Res; 1999 Aug; 8(4):401-10. PubMed ID: 10634178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization and transduction of peripheral blood progenitor cells in patients with mucopolysaccharidosis I.
    Hubel A; Stroncek D; Pan D; Whitley CB; McCullough J
    J Hematother; 1998 Dec; 7(6):505-14. PubMed ID: 9919944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome).
    Motas S; Haurigot V; Garcia M; Marcó S; Ribera A; Roca C; Sánchez X; Sánchez V; Molas M; Bertolin J; Maggioni L; León X; Ruberte J; Bosch F
    JCI Insight; 2016 Jun; 1(9):e86696. PubMed ID: 27699273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.